Amelioration of Cholesterol Rich diet-induced Impaired Cognition in AD Transgenic Mice by an LXR Agonist TO901317 Is Associated with the Activation of the LXR-β-RXR-α-ABCA1 Transmembrane Transport System and Improving the Composition of Lipid Raft
Saved in:
| Title: | Amelioration of Cholesterol Rich diet-induced Impaired Cognition in AD Transgenic Mice by an LXR Agonist TO901317 Is Associated with the Activation of the LXR-β-RXR-α-ABCA1 Transmembrane Transport System and Improving the Composition of Lipid Raft |
|---|---|
| Authors: | Na, Yang, Ke, Lin, Jie, Zhang, Jinping, Wang, Tao, Meng, Jie, Zhu, Liu, Yang, Yueqin, Zhou |
| Source: | Experimental Aging Research. May/Jun2023, Vol. 49 Issue 3, p214-225. 12p. 1 Diagram, 2 Charts, 4 Graphs. |
| Subjects: | Alzheimer's disease prevention, Learning assessment, Brain metabolism, Protein metabolism, In vitro studies, Memory, Animal behavior, In vivo studies, Animal experimentation, Western immunoblotting, Cognition, Cell receptors, Low density lipoproteins, Amyloid beta-protein precursor, Membrane glycoproteins, DNA-binding proteins, Enzyme-linked immunosorbent assay, Research funding, Colorimetry, High density lipoproteins, Dietary fats, Space perception, Cholesterol, Carrier proteins |
| Abstract: | It has been reported that LXR agonist can inhibit Aβ generation and alleviate Aβ-induced various adverse reactions in vivo and in vitro experiments, but the mechanisms have not been clarified. The study aimed to observe the effect of LXR agonist TO901317 on the cognitive function of AD transgenic mice fed with cholesterol-rich diet (CRD), and to explore the possible mechanism. Methods: 32 male 6-month-old double transgenic AD mice were enrolled and randomly divided into 4 groups: control (normal diet) group, CRD treatment group, TO901317 treatment group and GSK2033 treatment group. After 3 month, Morris water maze was for the changes of spatial exploration and memory ability; ELISA was for detecting the production of Aβ42 in the brain; the concentration of total cholesterol (TC), low density lipoprotein (LDL) and high density lipoprotein (HDL) in serum were detected by cholesterol enzyme colorimetry; Finally, the expression of LXR-β, RXR-α, ABCA1, caveolin-1, BACE1 and APP at protein level in the brains was measured by Western blotting. Compared with the control group, the learning, memory ability and spatial exploration ability of the mice were more significantly serious in the CRD group (P<0.05); The contents of TC and LDL in the serum and the production of Aβ42 in the brains were significantly increased (P<0.05), but HDL was remarkably decreased (P<0.05); The protein levels of LXR-β, RXR-α and ABCA1 were also significantly decreased (P<0.05); The expression of caveolin-1, APP and BACE1 were evidently increased (P<0.05). However, after treatment with TO901317, the impaired learning and memory and spatial exploration ability of the mice were significantly improved (P<0.05); The contents of TC and LDL in serum and the production of Aβ42 in the brains were significantly decreased (P<0.05), but HLD was increased (P<0.05); The protein levels of LXR-β, RXR-α, ABCA1were all significantly increased (P<0.05), while, the expression of caveolin-1, APP and BACE1 were all significantly decreased (P<0.05). All the changes were reversed by GSK2033 (P<0.05). TO901317 attenuated the more serious impairment of spatial exploration, learning and memory in transgenic AD mice induced by CRD, and the mechanism may be that TO901317 could activate the LXR-β/RXR-α/ABCA1 transmembrane transport system, promote the cholesterol efflux, and decreased caveolin-1, APP and BACE1, further reduce Aβ42 in the brains. [ABSTRACT FROM AUTHOR] |
| Copyright of Experimental Aging Research is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 162804636 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Amelioration of Cholesterol Rich diet-induced Impaired Cognition in AD Transgenic Mice by an LXR Agonist TO901317 Is Associated with the Activation of the LXR-β-RXR-α-ABCA1 Transmembrane Transport System and Improving the Composition of Lipid Raft – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Na%2C+Yang%22">Na, Yang</searchLink><br /><searchLink fieldCode="AR" term="%22Ke%2C+Lin%22">Ke, Lin</searchLink><br /><searchLink fieldCode="AR" term="%22Jie%2C+Zhang%22">Jie, Zhang</searchLink><br /><searchLink fieldCode="AR" term="%22Jinping%2C+Wang%22">Jinping, Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Tao%2C+Meng%22">Tao, Meng</searchLink><br /><searchLink fieldCode="AR" term="%22Jie%2C+Zhu%22">Jie, Zhu</searchLink><br /><searchLink fieldCode="AR" term="%22Liu%2C+Yang%22">Liu, Yang</searchLink><br /><searchLink fieldCode="AR" term="%22Yueqin%2C+Zhou%22">Yueqin, Zhou</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Experimental+Aging+Research%22">Experimental Aging Research</searchLink>. May/Jun2023, Vol. 49 Issue 3, p214-225. 12p. 1 Diagram, 2 Charts, 4 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Alzheimer's+disease+prevention%22">Alzheimer's disease prevention</searchLink><br /><searchLink fieldCode="DE" term="%22Learning+assessment%22">Learning assessment</searchLink><br /><searchLink fieldCode="DE" term="%22Brain+metabolism%22">Brain metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22Protein+metabolism%22">Protein metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22In+vitro+studies%22">In vitro studies</searchLink><br /><searchLink fieldCode="DE" term="%22Memory%22">Memory</searchLink><br /><searchLink fieldCode="DE" term="%22Animal+behavior%22">Animal behavior</searchLink><br /><searchLink fieldCode="DE" term="%22In+vivo+studies%22">In vivo studies</searchLink><br /><searchLink fieldCode="DE" term="%22Animal+experimentation%22">Animal experimentation</searchLink><br /><searchLink fieldCode="DE" term="%22Western+immunoblotting%22">Western immunoblotting</searchLink><br /><searchLink fieldCode="DE" term="%22Cognition%22">Cognition</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+receptors%22">Cell receptors</searchLink><br /><searchLink fieldCode="DE" term="%22Low+density+lipoproteins%22">Low density lipoproteins</searchLink><br /><searchLink fieldCode="DE" term="%22Amyloid+beta-protein+precursor%22">Amyloid beta-protein precursor</searchLink><br /><searchLink fieldCode="DE" term="%22Membrane+glycoproteins%22">Membrane glycoproteins</searchLink><br /><searchLink fieldCode="DE" term="%22DNA-binding+proteins%22">DNA-binding proteins</searchLink><br /><searchLink fieldCode="DE" term="%22Enzyme-linked+immunosorbent+assay%22">Enzyme-linked immunosorbent assay</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Colorimetry%22">Colorimetry</searchLink><br /><searchLink fieldCode="DE" term="%22High+density+lipoproteins%22">High density lipoproteins</searchLink><br /><searchLink fieldCode="DE" term="%22Dietary+fats%22">Dietary fats</searchLink><br /><searchLink fieldCode="DE" term="%22Space+perception%22">Space perception</searchLink><br /><searchLink fieldCode="DE" term="%22Cholesterol%22">Cholesterol</searchLink><br /><searchLink fieldCode="DE" term="%22Carrier+proteins%22">Carrier proteins</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: It has been reported that LXR agonist can inhibit Aβ generation and alleviate Aβ-induced various adverse reactions in vivo and in vitro experiments, but the mechanisms have not been clarified. The study aimed to observe the effect of LXR agonist TO901317 on the cognitive function of AD transgenic mice fed with cholesterol-rich diet (CRD), and to explore the possible mechanism. Methods: 32 male 6-month-old double transgenic AD mice were enrolled and randomly divided into 4 groups: control (normal diet) group, CRD treatment group, TO901317 treatment group and GSK2033 treatment group. After 3 month, Morris water maze was for the changes of spatial exploration and memory ability; ELISA was for detecting the production of Aβ42 in the brain; the concentration of total cholesterol (TC), low density lipoprotein (LDL) and high density lipoprotein (HDL) in serum were detected by cholesterol enzyme colorimetry; Finally, the expression of LXR-β, RXR-α, ABCA1, caveolin-1, BACE1 and APP at protein level in the brains was measured by Western blotting. Compared with the control group, the learning, memory ability and spatial exploration ability of the mice were more significantly serious in the CRD group (P<0.05); The contents of TC and LDL in the serum and the production of Aβ42 in the brains were significantly increased (P<0.05), but HDL was remarkably decreased (P<0.05); The protein levels of LXR-β, RXR-α and ABCA1 were also significantly decreased (P<0.05); The expression of caveolin-1, APP and BACE1 were evidently increased (P<0.05). However, after treatment with TO901317, the impaired learning and memory and spatial exploration ability of the mice were significantly improved (P<0.05); The contents of TC and LDL in serum and the production of Aβ42 in the brains were significantly decreased (P<0.05), but HLD was increased (P<0.05); The protein levels of LXR-β, RXR-α, ABCA1were all significantly increased (P<0.05), while, the expression of caveolin-1, APP and BACE1 were all significantly decreased (P<0.05). All the changes were reversed by GSK2033 (P<0.05). TO901317 attenuated the more serious impairment of spatial exploration, learning and memory in transgenic AD mice induced by CRD, and the mechanism may be that TO901317 could activate the LXR-β/RXR-α/ABCA1 transmembrane transport system, promote the cholesterol efflux, and decreased caveolin-1, APP and BACE1, further reduce Aβ42 in the brains. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Experimental Aging Research is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=162804636 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/0361073X.2022.2095605 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 214 Subjects: – SubjectFull: Alzheimer's disease prevention Type: general – SubjectFull: Learning assessment Type: general – SubjectFull: Brain metabolism Type: general – SubjectFull: Protein metabolism Type: general – SubjectFull: In vitro studies Type: general – SubjectFull: Memory Type: general – SubjectFull: Animal behavior Type: general – SubjectFull: In vivo studies Type: general – SubjectFull: Animal experimentation Type: general – SubjectFull: Western immunoblotting Type: general – SubjectFull: Cognition Type: general – SubjectFull: Cell receptors Type: general – SubjectFull: Low density lipoproteins Type: general – SubjectFull: Amyloid beta-protein precursor Type: general – SubjectFull: Membrane glycoproteins Type: general – SubjectFull: DNA-binding proteins Type: general – SubjectFull: Enzyme-linked immunosorbent assay Type: general – SubjectFull: Research funding Type: general – SubjectFull: Colorimetry Type: general – SubjectFull: High density lipoproteins Type: general – SubjectFull: Dietary fats Type: general – SubjectFull: Space perception Type: general – SubjectFull: Cholesterol Type: general – SubjectFull: Carrier proteins Type: general Titles: – TitleFull: Amelioration of Cholesterol Rich diet-induced Impaired Cognition in AD Transgenic Mice by an LXR Agonist TO901317 Is Associated with the Activation of the LXR-β-RXR-α-ABCA1 Transmembrane Transport System and Improving the Composition of Lipid Raft Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Na, Yang – PersonEntity: Name: NameFull: Ke, Lin – PersonEntity: Name: NameFull: Jie, Zhang – PersonEntity: Name: NameFull: Jinping, Wang – PersonEntity: Name: NameFull: Tao, Meng – PersonEntity: Name: NameFull: Jie, Zhu – PersonEntity: Name: NameFull: Liu, Yang – PersonEntity: Name: NameFull: Yueqin, Zhou IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May/Jun2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 0361073X Numbering: – Type: volume Value: 49 – Type: issue Value: 3 Titles: – TitleFull: Experimental Aging Research Type: main |
| ResultId | 1 |